Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1) -modulated P53 activity.
about
MicroRNAs in the Evaluation and Potential Treatment of Liver DiseasesMicroRNAs as Biomarkers for Liver Disease and Hepatocellular CarcinomaAutophagy and microRNA in hepatitis B virus-related hepatocellular carcinomaMicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic ConsiderationsMicroRNAs as Important Players in Host-hepatitis B Virus InteractionsHepatitis B Virus Infection, MicroRNAs and Liver DiseaseMicroRNAs may solve the mystery of chronic hepatitis B virus infectionmiR-122 is a unique molecule with great potential in diagnosis, prognosis of liver disease, and therapy both as miRNA mimic and antimirMiR-122 in hepatitis B virus and hepatitis C virus dual infectionHepatitis B virus and microRNAs: Complex interactions affecting hepatitis B virus replication and hepatitis B virus-associated diseasesHost cellular microRNA involvement in the control of hepatitis B virus gene expression and replicationThe L60V Variation in Hepatitis B Virus Core Protein Elicits New Epitope-Specific Cytotoxic T Lymphocytes and Enhances Viral ReplicationRoles of hepatocyte nuclear factors in hepatitis B virus infectionTP53/MicroRNA Interplay in Hepatocellular CarcinomaHepatitis B virus molecular biology and pathogenesisGenome-wide identification of direct HBx genomic targetsmicroRNA-122 abundance in hepatocellular carcinoma and non-tumor liver tissue from Japanese patients with persistent HCV versus HBV infection.Serum microRNA-122 and Wisteria floribunda agglutinin-positive Mac-2 binding protein are useful tools for liquid biopsy of the patients with hepatitis B virus and advanced liver fibrosis.MicroRNAs as therapeutic strategy for hepatitis B virus-associated hepatocellular carcinoma: current status and future prospectsModulation of HBV replication by microRNA-15b through targeting hepatocyte nuclear factor 1αmiRNAs affect the development of hepatocellular carcinoma via dysregulation of their biogenesis and expression.MiRNA-548ah, a potential molecule associated with transition from immune tolerance to immune activation of chronic hepatitis B.Alcohol facilitates HCV RNA replication via up-regulation of miR-122 expression and inhibition of cyclin G1 in human hepatoma cellsMicroRNAs associated with HBV infection and HBV-related HCC.Complex interactions between microRNAs and hepatitis B/C viruses.Inhibition of alpha interferon (IFN-α)-induced microRNA-122 negatively affects the anti-hepatitis B virus efficiency of IFN-α.Association of polymorphism in pri-microRNAs-371-372-373 with the occurrence of hepatocellular carcinoma in hepatitis B virus infected patients.Hepatitis C virus represses the cellular antiviral response by upregulating the expression of signal transducer and activator of transcription 3 through sponging microRNA‑122Hepatitis B virus-specific miRNAs and Argonaute2 play a role in the viral life cycle.Differential plasma microRNA profiles in HBeAg positive and HBeAg negative children with chronic hepatitis BMicroRNA-26b inhibits hepatitis B virus transcription and replication by targeting the host factor CHORDC1 proteinIncreased expression of Gp96 by HBx-induced NF-κB activation feedback enhances hepatitis B virus productionDecreased expression of hepatocyte nuclear factor 4α (Hnf4α)/microRNA-122 (miR-122) axis in hepatitis B virus-associated hepatocellular carcinoma enhances potential oncogenic GALNT10 protein activity.MicroRNA miR-21 attenuates human cytomegalovirus replication in neural cells by targeting Cdc25a.HBx down-regulated Gld2 plays a critical role in HBV-related dysregulation of miR-122The "Macro" World of microRNAs in Hepatocellular Carcinoma.Possible role of tocopherols in the modulation of host microRNA with potential antiviral activity in patients with hepatitis B virus-related persistent infection: a systematic review.Cellular microRNA miR-26a suppresses replication of porcine reproductive and respiratory syndrome virus by activating innate antiviral immunity.A cross-talk between Hepatitis B virus and host mRNAs confers viral adaptation to liverMicroRNA-122 Inhibits the Production of Inflammatory Cytokines by Targeting the PKR Activator PACT in Human Hepatic Stellate Cells
P2860
Q26750448-0AE8AF28-237F-42E2-BA86-18CA0750E7B6Q26765476-4F5947B2-A259-4F8E-A8E3-EFAA8E63BEF3Q26772338-D3C2BC95-C605-4CF0-BA09-1A663839C498Q26773183-E9FA6FFA-FB9A-452C-B871-CB52B6C0E3D0Q26781737-4C78C492-07C0-4865-A41F-B3B6EBD35648Q26801511-A9897A7E-BC5F-46AE-83D3-1F28D676D89AQ26827668-28515CBF-7644-4077-9AAD-64AB87E92FDBQ26991956-B92172C8-FD84-42F0-830A-460F4D41DAACQ27008894-BF971486-14D6-4C83-9FB5-23FB4417F11CQ27024630-277F49CE-C777-478A-9F0D-9F6F6C2BBB8DQ27027473-2D447755-66B0-413D-B9B6-52AEAD12420DQ27678163-74CF652D-C072-4F28-ABA3-870EFDE9768DQ28069574-74AC218B-89BB-460B-9B7E-6732E842F8B1Q28073980-495923D3-683C-4B6B-B6B4-E7015238415EQ28818406-831B34D0-0FBC-4440-A232-284CB48ED0FEQ29048191-70D952C8-D90C-4900-9C1B-ADCC1D5CDF67Q31141908-597B6D33-41AD-4DC5-B6C6-6C41D726362BQ33643388-225D0947-BE97-4995-87C7-ED4B53761339Q33661037-703B6E37-9272-43BF-AF23-F8BFED4C802EQ33698542-57D82100-8019-4998-97C0-F449D52D3541Q33980238-4B1A05BB-4BB9-456C-8DC4-4C3D7F30FDA1Q34158620-3CD6D851-8687-4970-A77E-CFDE8599FF14Q34228009-7596CB3A-DAAA-4D8E-A655-E30675735768Q34284404-3D021BDC-C37E-4F09-A0F1-330FDEF589C7Q34302987-E03E3085-E67C-4D30-9649-C9F7925E85C3Q34305346-36F8AA9E-0BD4-41AC-902A-9C33AC6C3D52Q34359354-0BDC1813-D7F8-4F12-B76A-116A3F78B94DQ34446691-60A1F22B-61A4-43A3-ACD3-E9E4FC684F80Q34455269-6423756A-087F-4A1A-B077-65721C66F61CQ34613446-0BD9A403-0147-4BBA-9F54-3F251D98C087Q34683454-6511391A-11BE-47EC-975B-CE10BFEC7D18Q34775798-B58CBB3A-4196-422A-A5B2-BC345AD42833Q34958488-406E46E3-E4B9-4B3E-9694-B58B947E9CD5Q34991006-E51E0CEE-DC4E-41D4-98F5-6FF1D5CFC798Q35131026-687698DE-55A7-4124-B339-0D11FACE6173Q35215896-FEBDC68E-B135-46EF-8896-5BD5917F636DQ35343911-E6AC7295-0E04-4ABB-AC28-3C38598A389CQ35651246-EFF9546E-749F-421E-985C-583ABDCC5325Q35860325-588A6BC5-DCEB-49CE-9521-098E4F907AF4Q35861037-4BCF212F-8D5C-4DBA-9690-DC7FA2EB83EF
P2860
Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1) -modulated P53 activity.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Loss of microRNA 122 expressio ...... s replication through cyclin G
@nl
Loss of microRNA 122 expressio ...... G(1) -modulated P53 activity.
@en
type
label
Loss of microRNA 122 expressio ...... s replication through cyclin G
@nl
Loss of microRNA 122 expressio ...... G(1) -modulated P53 activity.
@en
prefLabel
Loss of microRNA 122 expressio ...... s replication through cyclin G
@nl
Loss of microRNA 122 expressio ...... G(1) -modulated P53 activity.
@en
P2093
P2860
P356
P1433
P1476
Loss of microRNA 122 expressio ...... G(1) -modulated P53 activity.
@en
P2093
Fusheng Wang
Lizhao Chen
Saifeng Wang
Songdong Meng
Wensong Jin
Xiaoli Yan
Yanzhong Wang
P2860
P304
P356
10.1002/HEP.24809
P407
P577
2012-03-01T00:00:00Z